In the liver of the animal models of NAFLD and NASH patients, the NF-κB signaling pathway is continuously active, and its IKK2 subunit is upregulated [82,83]. The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatotic liver disease.